CIPLA.NS - Cipla Limited

NSE - NSE Real-time price. Currency in INR
965.85
+1.10 (+0.11%)
At close: 03:29PM IST
Stock chart is not supported by your current browser
Previous close964.75
Open965.90
Bid0.00 x 0
Ask0.00 x 0
Day's range954.65 - 969.65
52-week range852.00 - 1,185.25
Volume1,098,445
Avg. volume2,322,902
Market cap779.657B
Beta (5Y monthly)0.31
PE ratio (TTM)27.50
EPS (TTM)35.12
Earnings date27 July 2023 - 31 July 2023
Forward dividend & yield8.50 (0.88%)
Ex-dividend date20 July 2023
1y target est1,060.63
  • PR Newswire

    CIPLA ANNOUNCES LAUNCH OF LEUPROLIDE ACETATE INJECTION DEPOT (22.5Mg)

    Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) and its wholly owned subsidiary Cipla USA Inc. (hereafter referred to as 'Cipla'), today announced the launch of Leuprolide Acetate Injection Depot 22.5mg. The product was approved by the United States Food and Drug Administration ('US FDA') based on a New Drug Application (NDA) submitted under the 505(b)(2) regulatory pathway.